Replies to post #390547 on NorthWest Biotherapeutics Inc (NWBO)

[ATLnsider]

Jerry, please read this directly from NWBio’s website. I do agree that they are not currently recruiting new patients into the DCVax Direct Phase II trial, because of a lack of funds plus the focus on DCVax-L data release & ultimate approval by RAs, but they are continuing to track and treat those patients who have already been treated with DCVax Direct:

We are currently conducting a 60-patient Phase I/II trial of DCVax-Direct for all types of inoperable solid tumors. The trial is under way at MD Anderson in Houston, TX and MD Anderson in Orlando, FL, with additional sites in varying stages of preparation. The Phase I stage of the trial involves dose escalation, testing 3 different dose levels of DCVax-Direct, and confirmation of the optimal dose.

https://nwbio.com/dcvax-direct/